The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Banda, N. K.
Right arrow Articles by Arend, W. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Banda, N. K.
Right arrow Articles by Arend, W. P.
The Journal of Immunology, 2003, 171: 2109-2115.
Copyright © 2003 by The American Association of Immunologists

Prevention of Collagen-Induced Arthritis in Mice Transgenic for the Complement Inhibitor Complement Receptor 1-Related Gene/Protein y1

Nirmal K. Banda*, Damian M. Kraus*, Michele Muggli*, Alison Bendele{dagger}, V. Michael Holers* and William P. Arend2,*

* Division of Rheumatology, University of Colorado Health Sciences Center, Denver, CO 80262; and {dagger} BolderPATH, Boulder, CO 80309

The objective of these studies was to examine collagen-induced arthritis (CIA) in C57BL/6 mice transgenic for the rodent complement regulatory protein complement receptor 1-related gene/protein y (Crry) (Crry-Tg), a C3 convertase inhibitor. The scores for clinical disease activity and for histological damage in the joints were both significantly decreased in Crry-Tg mice in comparison to wild-type (WT) littermates. The production of both IgG1 and IgG2a anti-collagen Abs was reduced in the Crry-Tg mice, although spleen cell proliferation in response to collagen type II was not altered. The production of IFN-{gamma}, TNF-{alpha}, and IL-1{beta} by LPS-stimulated spleen cells was decreased, and IL-10 was increased, in cells from Crry-Tg mice in comparison to WT. The steady-state mRNA levels for IFN-{gamma}, TNF-{alpha}, and IL-1{beta} were all decreased in the joints of Crry-Tg mice in comparison to WT. The synovium from Crry-Tg mice without CIA contained the mRNA for the Crry transgene, by RT-PCR, and the synovium from transgenic mice with CIA exhibited little deposition of C3 protein by immunohistological analysis. These results suggest that suppression of CIA in Crry-Tg mice may be due to enhanced synthesis of Crry locally in the joint with decreased production of proinflammatory cytokines.




This article has been cited by other articles:


Home page
J. Immunol.Home page
N. K. Banda, B. Levitt, M. J. Glogowska, J. M. Thurman, K. Takahashi, G. L. Stahl, S. Tomlinson, W. P. Arend, and V. M. Holers
Targeted Inhibition of the Complement Alternative Pathway with Complement Receptor 2 and Factor H Attenuates Collagen Antibody-Induced Arthritis in Mice
J. Immunol., November 1, 2009; 183(9): 5928 - 5937.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Song, F. Qiao, C. Atkinson, V. M. Holers, and S. Tomlinson
A Complement C3 Inhibitor Specifically Targeted to Sites of Complement Activation Effectively Ameliorates Collagen-Induced Arthritis in DBA/1J Mice
J. Immunol., December 1, 2007; 179(11): 7860 - 7867.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
K. J. Katschke Jr., K. Y. Helmy, M. Steffek, H. Xi, J. Yin, W. P. Lee, P. Gribling, K. H. Barck, R. A.D. Carano, R. E. Taylor, et al.
A novel inhibitor of the alternative pathway of complement reverses inflammation and bone destruction in experimental arthritis
J. Exp. Med., June 11, 2007; 204(6): 1319 - 1325.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. K. Banda, J. M. Thurman, D. Kraus, A. Wood, M. C. Carroll, W. P. Arend, and V. M. Holers
Alternative Complement Pathway Activation Is Essential for Inflammation and Joint Destruction in the Passive Transfer Model of Collagen-Induced Arthritis
J. Immunol., August 1, 2006; 177(3): 1904 - 1912.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. J. Del Nagro, R. V. Kolla, and R. C. Rickert
A Critical Role for Complement C3d and the B Cell Coreceptor (CD19/CD21) Complex in the Initiation of Inflammatory Arthritis
J. Immunol., October 15, 2005; 175(8): 5379 - 5389.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.